Clinical Trials Browser

Interventional × Lymphopenia × Injections × Clear all

NCT06584006 2024-09-19

Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors

Phase 2 Recruiting

Other hematologic neoplasm

Lymphopenia, Hematologic Neoplasms